MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Consolidation of learning and memory in Parkinson’s disease

M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

Meeting: 2016 International Congress

Abstract Number: 1452

Keywords: Cognitive dysfunction, Dopamine

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To determine if Parkinson’s disease causes an impairment in the ability to consolidate learning into long-term memory and to determine if this deficit is dopamine-dependent.

Background: Loss of dopamine in Parkinson’s disease has been associated with reduced plasticity but little is known about the behavioral and cognitive consequences of this reduced plasticity. One important role of plasticity is the consolidation of learning into long-term memory. In this study, we aimed to identify whether Parkinson’s disease, and specifically dopamine loss, lead to reduced consolidation of learning. Indeed, it is widely accepted that dopamine plays an important role in multiple aspects of learning and that Parkinson’s patients have a learning deficit, but dopamine’s role in the consolidation of learning is not well understood.

Methods: We used a task that measures two types of learning: probabilistic incremental learning and episodic memory. To test the effect of Parkinson’s disease and dopamine on the consolidation of incremental learning and episodic memory, we tested healthy controls and participants with Parkinson’s disease, either ON or OFF their dopaminergic medications. Consolidation was measured by testing the persistence of learning at two time points across a two-day delay.

Results: Initial learning was similar among Parkinson’s patients and controls, but Parkinson’s patients showed weaker consolidation than controls for both incremental learning and episodic memory. Early results also suggest that dopamine replacement at the time of initial learning improved consolidation of incremental learning. This effect was not seen for episodic memory.

Conclusions: These findings suggest that Parkinson’s patients have weaker consolidation of both incremental and episodic memory, but that dopamine might play a selective role in the consolidation of certain types of learning. Future work is needed to determine whether weaker consolidation in Parkinson’s patients can be linked more generally to reduced plasticity and whether therapies thought to influence plasticity, such as deep brain stimulation, can also have beneficial effects on consolidation processes.

Parts of the data described here were presented at the Society for Neuroscience meeting in October 2015.

To cite this abstract in AMA style:

M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy. Consolidation of learning and memory in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/consolidation-of-learning-and-memory-in-parkinsons-disease/. Accessed May 14, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/consolidation-of-learning-and-memory-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley